TARGETED CLINICAL TRIALS TO REDUCE THE RISK OF ANTIMICROBIAL RESISTANCE
$8,509,190N01FY2017AINIH
University Of Michigan At Ann Arbor, Ann Arbor MI
Investigators
Abstract
To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure.
View original record on NIH RePORTER →